Ginkgo Bioworks
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $20,156 | $19,474 | $33,396 | $38,837 |
Gross Profit | 18,437 | 3,577 | 41,546 | 26,035 |
EBITDA | -44,356 | -63,340 | -34,869 | -66,586 |
EBIT | -56,671 | -76,139 | -81,394 | -80,754 |
Net Income | -46,710 | -82,587 | -80,751 | -80,755 |
Net Change In Cash | 20,156 | 19,474 | 33,396 | 38,837 |
Free Cash Flow | -46,892 | -48,619 | -63,003 | -31,606 |
Cash | 84,535 | 143,864 | 167,202 | 111,065 |
Basic Shares | 62,094 | 59,563 | 55,457 | 55,633 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $170,155 | $227,043 | $251,455 | $477,706 |
Gross Profit | 138,634 | 188,494 | 197,450 | 273,490 |
EBITDA | -254,610 | -484,394 | -821,293 | -2,059,659 |
EBIT | -313,600 | -547,414 | -892,847 | -2,121,293 |
Net Income | -312,763 | -547,029 | -892,869 | -2,104,929 |
Net Change In Cash | 170,155 | 227,043 | 251,455 | 477,706 |
Cost of Revenue | -224,255 | |||
Free Cash Flow | -178,724 | -382,126 | -336,301 | -304,469 |
Cash | 167,202 | 561,572 | 944,073 | 1,315,792 |
Basic Shares | 55,457 | 51,894 | 48,610 | 41,995 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.86 |
2026-03-31 | -$1.39 |
2025-12-31 | -$1.42 |
2025-09-30 | -$1.45 |